New Delhi: After Prime Minister Narendra Modi made an explicit call on 15 August to vaccinate the Covid-19 from the ramparts of the Red Fort, bureaucrats are alerted. Dr VK The Prime Minister’s own task force, led by Paul, went into action and began scouting for the purchase of the vaccine. Although the Task Force on Vaccines was created in early March this year, it made virtually no progress.
Although India is a global centre for vaccine production for leading pharmaceutical companies, there was no attempt to talk to them. There are 7 leading vaccine manufacturers in India, which have the capacity to produce 3 billion doses per year. The corona epidemic affected 20 per cent of the world’s population, and a minimum of 5 per cent of the population may need a vaccine. There is a huge demand for this globally.
Global pharmaceutical companies have received at least $ 5 billion from countries such as the United States, Britain, the European Union, Japan and Switzerland in exchange for a commitment to make the vaccine available soon. These companies have played their claim. Nothing is clear yet as to whether the vaccines will be successful or not, as most of them are in Phase-I, Phase-2 and Phase-3 trials. At the same time, only 7-8 of the 140 vaccine companies involved in drug manufacturing are in various stages of human testing. Happily, 4 vaccines of India are included in this.
They are Covaxin (Bharat Biotech – ICMR), Zydus CV. (Zydus Cadila), COVID Shield (Oxford University-Serum Institute, Pune) and one with Johnson & Johnson being manufactured by e-organic of Hyderabad. Synovial Biotec and Russia’s Sputnik-5 have not yet approached India for testing and production. Sputnik-5 has completed the Phase-2 trial, but the Indian government is yet to spend money on signing contracts with manufacturers and global pharmaceutical companies to purchase and manufacture the vaccine. Interestingly, officials are meeting one after the other to discuss this issue. Some leading vaccine companies have also asked the government to give information about their needs, which will help them to build on a large scale. The Indian Council of Medical Research collaborated for the research and produced vaccine with Bharat Biotech for which phase-2 trials are underway, but hardly any major funding has been given for it.